Chromatin, Inc. Closes New Financing Round, Adds Private Equity Investors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHICAGO--(BUSINESS WIRE)--Chromatin, Inc., an agriculture technology company, today announced the first closing of its Series E financing round, expected to total $36 million. Wood Creek Capital Management, an investment manager focused on investing in real assets and intellectual property, including agricultural resources, led the round. Other participants included GE Capital, Equity, as well as funds that had participated in earlier rounds of financing: BP Alternative Energy, IllinoisVentures, the State of Wisconsin Investment Board, and Adventures IV, LLC. With its Series E round, Chromatin has successfully raised over $70 million of equity in aggregate.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC